Maven Brands (TRLFF) 1-U Current report (pursuant to Regulation A)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 1-U

CURRENT REPORT PURSUANT REGULATION A

Date of Report (Date of earliest event reported) July 5, 2018

True Leaf Medicine International Ltd.
(Exact name of registrant as specified in its charter)
British Columbia	000-00000
State or other jurisdiction of incorporation or organization	(I.R.S. Employer
	Identification No.)
100 Kalamalka Lake Road, Unit 32, Vernon, British Columbia V1T 9G1
(Full mailing address of principal executive offices)
778-389-9933
Issuer's telephone number, including area code
Title of each class of securities issued pursuant to Regulation A:	Common Shares

Item 9.    Other Events

Press Release

On July 5, 2018, True Leaf Medicine International Ltd. (the "Issuer") issued a release to announce it will host a conference call to discuss its fiscal year 2018 financial results first announced on June 28, 2018.

Item 10.          Exhibits

15.1     Press Release dated July 5, 2018

SIGNATURES

Pursuant to the requirements of Regulation A, the issuer has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

True Leaf Medicine International Ltd.

	/s/ Darcy Bomford
By:
	Darcy Bomford
	Chief Executive Officer of True Leaf

Date:  July 5, 2018